This trade activity should not be overlooked: CVS Health Corp (CVS)

With 10.09 million shares changed hands, the volume of the stock remained lighter than its average volume of 10.18 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $69.6 whereas the lowest price it dropped to was $68.86. The 52-week range on CVS shows that it touched its highest point at $83.25 and its lowest point at $64.41 during that stretch. It currently has a 1-year price target of $87.91. With its current market cap of 87.32 billion, CVS has annualized dividend of $2.48 while the current yield stands at 3.57%. Beta for the stock currently stands at 0.55.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CVS was down-trending over the past week, with a drop of -0.50%, but this was down by -11.11% over a month. Three-month performance dropped to -6.08% while six-month performance fell -3.64%. The stock lost -8.87% in the past year, while it has lost -12.12% so far this year. A look at the trailing 12-month EPS for CVS yields 6.47 with Next year EPS estimates of 9.17. For the next quarter, that number is 1.71. This implies an EPS growth rate of -5.17% for this year and 10.59% for next year.

Float and Shares Shorts:

At present, 1.29 billion CVS shares are outstanding with a float of 1.26 billion shares on hand for trading. On 2024-03-28, short shares totaled 22.72 million, which was 179.99999999999997 higher than short shares on 1709164800. In addition to Ms. Karen Sue Lynch as the firm’s President, CEO & Director, Mr. Thomas Francis Cowhey serves as its Executive VP & CFO.

Institutional Ownership:

Through their ownership of 0.82795995 of CVS’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2023-12-31, CVS reported revenue of $93813000000.0 and operating income of $3373000000.0. The EBITDA in the recently reported quarter was $4529000000.0 and diluted EPS was $1.58.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CVS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.